Long-Term Maintenance of Complete Response after Sorafenib Treatment for Multiple Lung Metastases from Hepatocellular Carcinoma

Sorafenib is an effective treatment for unresectable hepatocellular carcinoma (HCC) characterized by disease stabilization. However, the response rates are very low (<9%percnt;), and a complete response is rarely achieved. We report an extremely rare case of a HCC patient with multiple lung metas...

Descripción completa

Detalles Bibliográficos
Autores principales: Katafuchi, Eisuke, Takami, Yuko, Wada, Yoshiyuki, Tateishi, Masaki, Ryu, Tomoki, Mikagi, Kazuhiro, Saitsu, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Published online: August, 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560326/
https://www.ncbi.nlm.nih.gov/pubmed/26351418
http://dx.doi.org/10.1159/000438746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560326/
https://www.ncbi.nlm.nih.gov/pubmed/26351418
http://dx.doi.org/10.1159/000438746

Ejemplares similares